ZyVersa Therapeutics, Inc. (ZVSA): Total Assets
$347.9K
As of 2025-12-31
$742.2K
As of 2026-03-31
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $347.9K | -98.3% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $20.60M | -6.9% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $22.11M | n/a | 2025-03-27, Balance as of period end |
| No annual figure between 2021-12-31 and 2023-12-31. | |||
| 2021-12-31 | $77.14M | n/a | 2022-04-15, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| ZyVersa Therapeutics, Inc. (ZVSA) | 2025-12-31 | $347.9K | -98.3% |
| Bespoke Extracts, Inc. (BSPK) | 2024-12-31 | $359.1K | +1.3% |
| Polomar Health Services, Inc. (PMHS) | 2025-12-31 | $390.0K | -96.1% |
| America Great Health (AAGH) | 2025-06-30 | $301.8K | -6.7% |
| Cell Source, Inc. (CLCS) | 2024-12-31 | $286.5K | +46.8% |
| Bio Essence Corp (BIOE) | 2025-12-31 | $422.5K | +50.3% |
| Regen BioPharma Inc (RGBP) | 2025-09-30 | $274.6K | +70.5% |
| ProtoKinetix, Inc. (PKTX) | 2025-12-31 | $483.4K | +3.7% |
| Bioadaptives, Inc. (BDPT) | 2025-12-31 | $225.9K | -13.7% |
Compare ZVSA, BSPK, PMHS, AAGH side by side · Screen every company in Pharmaceutical Preparations ↗